[The value of sepsis isolation to diminish the spread of multidrug-resistant bacteria in intensive care. Consequences on the incidence of nosocomial infections].
Bercault
N
N
Linassier
P
P
D000151:Acinetobacter Infections / Q000517:prevention & control*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D003422:Critical Care; D003428:Cross Infection / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007710:Klebsiella Infections / Q000517:prevention & control*; D007711:Klebsiella pneumoniae / Q000187:drug effects*; D008875:Middle Aged; D010356:Patient Isolation; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D003091:Colistin